Doxorubicin and Docetaxel in Treating Women With Stage III Breast Cancer

NCT00005800 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

45

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

BIOLOGICAL: Filgrastim
DRUG: Docetaxel
DRUG: Doxorubicin
PROCEDURE: Surgery

Sponsor

H. Lee Moffitt Cancer Center and Research Institute

Collaborators

[object Object]
[object Object]